The global irritable bowel syndrome treatment market is projected to grow at a compound annual growth rate (CAGR) of 8.6% during the forecast period 2021-2027, according to the new report published by our report Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global irritable bowel syndrome treatment market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.

The irritable bowel syndrome treatment market is segmented on the basis of type, product, distribution channel, and region. The irritable bowel syndrome treatment market is segmented as below:

By Type:

IBS with constipation (IBS-C)
IBS with diarrhea (IBS-D)
mixed-presentation IBS (IBS-M)
By Product:
eluxadoline
linaclotide
lubiprostone
rifaximin
others
By Distribution Channel:
drug stores and retail pharmacies
hospitals pharmacies
online pharmacies
others
By Region:
region
Asia-Pacific
Europe
North America
Middle East and Africa (MEA)
South America
The irritable bowel syndrome treatment industry is characterized by a high level of market share concentration. The market research report covers the analysis of key stake holders of the irritable bowel syndrome treatment market. Some of the leading players profiled in the report include Abbott Laboratories, Allergan plc, Ardelyx, Inc., Astellas Pharma Inc., AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, The Takeda Pharmaceutical Company Limited, among others.

*list is not exhaustive, request free sample to get a complete list of companies

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
To analyze and forecast the market size of the global irritable bowel syndrome treatment market.
To classify and forecast the global irritable bowel syndrome treatment market based on type, product, distribution channel, and region.
To identify drivers and challenges for the global irritable bowel syndrome treatment market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global irritable bowel syndrome treatment market.
To conduct pricing analysis for the global irritable bowel syndrome treatment market.
To identify and analyze the profile of leading players operating in the global irritable bowel syndrome treatment market.
Why Choose This Report
Gain a reliable outlook of the global irritable bowel syndrome treatment market forecasts from 2021 to 2027 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.